INmune Bio Inc share price logo

INmune Bio Inc Share Price

NASDAQ: INMB

Small Cap

$1.49

+0.04

(+2.76%)

as on

INmune Bio Inc Stock Performance

as on April 21, 2026 at 6:59 am IST

  • Day's Low

    $1.41
    $1.49
    downward going graph

    5.37%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.09
    $11.64
    downward going graph

    26.85%

    Downside

    681.21%

    Upside

    downward going graph

INmune Bio Inc share price movements today

Previous Close
$1.45
Open
$1.44
Volume
337.5K
Day's Low - High
$1.41 - $1.49
52 Week Low - High
$1.09 - $11.64

INmune Bio Inc Historical Returns

1 Month Return
+ 27.35 %
3 Month Return
-9.15 %
1 Year Return
-79.53 %
3 Year Return
-79.73 %
5 Year Return
0 %

INmune Bio Inc Stock Fundamentals & Key Indicators

Check INmune Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.6M

EPS (TTM)

-0.65

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-30.8M

Revenue (TTM)

50.0K

Profit Margin

0.00%

Return On Equity TTM

-165.16%

INmune Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of INmune Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$39.6MNANA0.00%
BUY$41.3B126.09%133.478.45%
BUY$111.7B99.85%28.6532.94%
NA$36.5BNA128.255.37%
BUY$79.2B47.96%18.0531.41%

Stock Returns calculator for INmune Bio Inc Stock including INR - Dollar returns

The INmune Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

INmune Bio Inc investment value today

Current value as on today

₹22,372

Returns

-₹77,628

(-77.63%)

Returns from INmune Bio Inc Stock

-₹79,533 (-79.53%)

Dollar Impact

₹1,905 (+1.9%)

Analyst Recommendation on INmune Bio Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for INmune Bio Inc. Average target price of $7

INmune Bio Inc Share Price Target

Get share price movements and forecasts by analysts on INmune Bio Inc.

What analysts predicted

78.71%UPSIDE

Target Price

$7

Current Price

$1.49

Analyzed by

9 Analysts

Target

$7.00

INmune Bio Inc target price $7, a slight upside of 78.71% compared to current price of $1.49. According to 9 analysts rating.

INmune Bio Inc Stock’s Investor Sentiment and Interest

Search interest for INmune Bio Inc Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

INmune Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
-
-
-
0
-
-
-
Gross Profit
0
0
0
-
-
-
0
-
0
0
Operating Income
-8
-8
-11
-9
-12
-9
-9
-24
-7
-5
EBITDA
-8
-8
-11
-9
-12
-9
-9
-8
-6
-5
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
0
Income Before Tax
-8
-8
-11
-9
-12
-9
-9
-24
-6
-5
Income Tax Expense
-8
14
-11
-9
-
-
-
-
-
-
Net Income
-8
-8
-11
-9
-12
-9
-9
-24
-6
-5
Net Profit Margin
-19913.95%
-30028.57%
-78750.00%
0.00%
0.00%
0.00%
-19478.00%
0.00%
0.00%
0.00%

INmune Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
77
0
0
0
0
0
0
Gross Profit
-
-
-
77
0
0
0
0
0
0
Operating Income
0
0
-12
-7
-12
-29
-25
-29
-42
-30
EBITDA
0
0
-12
-7
-12
-30
-27
-29
-42
-30
Interest Expense
-
-
-
-
-
1
1
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
0
Income Before Tax
0
0
-12
-7
-12
-30
-27
-30
-42
-45
Income Tax Expense
0
-1
0
1
0
1
1
-29
-
-
Net Income
0
0
-12
-7
-12
-30
-28
-30
-42
-45
Net Profit Margin
0.00%
0.00%
0.00%
-9.88%
-110838.76%
-16762.43%
-7659.63%
-19360.00%
-300585.71%
-91866.00%

INmune Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-8
-11
-9
-12
-9
-9
-24
-6
40
Operating Cash Flow
-3
-7
-7
-6
-11
-6
-7
-5
-2
Investing Cash Flow
2
-
-
-
-
-
0
0
0
Financing Cash Flow
-2
-2
12
9
-2
5
22
-
0
Change in Cash
-5
-9
5
2
-12
-1
14
-5
-2

INmune Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-12
-7
-12
-30
-27
-30
-42
-45
Operating Cash Flow
0
-2
-5
-8
-28
-22
-11
-33
-22
Investing Cash Flow
0
-15
-15
-15
-15
-
-
-
-1
Financing Cash Flow
2
0
12
23
96
0
-4
18
27
Change in Cash
1
-1
6
14
52
-22
-16
-14
3

Global Institutional Holdings in INmune Bio Inc

Funds
Holdings
Mccormack Advisors International
0.18%
Laird Norton Tyee Trust Co
0.17%
Barclays PLC
0.11%
State Street Corp
1.07%
Jane Street Group LLC
0.19%

Insights on INmune Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, INMB stock has moved up by 15.1%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -24.45M → -5.26M (in $), with an average increase of 150.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 14.0K → 50.0K (in $), with an average increase of 72.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 41.3% return, outperforming this stock by 121.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 105.6%

About INmune Bio Inc

INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; GOSH; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
OrganisationINmune Bio Inc
Headquarters225 NE Mizner Blvd., Boca Raton, FL, United States, 33432
IndustryBiotechnology
CEOMr. David J. Moss M.B.A.
E-voting on sharesClick here to vote

Key Management of INmune Bio Inc

Name

Title

Mr. David J. Moss M.B.A.

President, CEO, Treasurer, Secretary & Director

Dr. Mark William Lowdell Ph.D.

Chief Scientific Officer & Chief Manufacturing Officer

Mr. Cory Randall Ellspermann

Interim Chief Financial Officer

Mr. Daniel Frederick Carlson

Head of Investor Relations

Mr. Joshua S. Schoonover Esq.

General Counsel

FAQs

What is INmune Bio Inc share price today?

INmune Bio Inc share price today is $1.49 as on at the close of the market. INmune Bio Inc share today touched a day high of $1.49 and a low of $1.41.

What is the 52 week high and 52 week low for INmune Bio Inc share?

INmune Bio Inc share touched a 52 week high of $11.64 on and a 52 week low of $1.09 on . INmune Bio Inc stock price today i.e. is closed at $1.49,which is 87.20% down from its 52 week high and 36.70% up from its 52 week low.

What is INmune Bio Inc's market capitalisation today?

INmune Bio Inc market capitalisation is $0.00T as on .

How to invest in INmune Bio Inc Stock (INMB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for INmune Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in INmune Bio Inc Shares that will get you 1.0067 shares as per INmune Bio Inc share price of $1.49 per share as on April 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy INmune Bio Inc Stock (INMB) from India?

Indian investors can start investing in INmune Bio Inc (INMB) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in INmune Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on INmune Bio Inc share’s latest price of $1.49 as on April 21, 2026 at 1:29 am IST, you will get 6.7114 shares of INmune Bio Inc. Learn more about fractional shares .